Denali Therapeutics

Denali Therapeutics is a biotechnology company focused on developing therapies for neurodegenerative and lysosomal storage diseases. It generates revenue primarily from collaboration and license agreements, including partnerships with larger pharmaceutical companies, while advancing a clinical pipeline of drug candidates.

Relationship details are part of the Pro plan.